Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSP
Apollo Hospitals Enterprise — Q3 FY24 Earnings Presentation
30 slides from Apollo Hospitals Enterprise's earnings presentation, Feb 8, 2024
Slide 1: Regulation 30 disclosure letter to stock exchanges
II• APOLLO HOSPITALS ENTERPRISE LIMITED A"'b110 ~OSPITALS CIN : L8511 OTN1979PLC008035 sth February 2024 The Secretary, The Secretary, The Manager Bombay Stock Exchange Ltd (BSE) National Stock Exchange, The National Stock Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor Exchange, Dalal Street
Slide 2: Apollo Hospitals Enterprise Limited Earnings Update Q3 FY24
APOLLO HOSPITALS ENTERPRISE LIMITED Earnings Update Q3 FY24
Slide 3: Agenda
01 Operational & 02 Consolidated 03 Healthcare Services Financial Snapshot Financials 04 05 Digital Health 06 Annexure Diagnostics & Retail Health (AHLL) & Pharmacy Distribution (Apollo HealthCo) 2
Slide 4: Operational & Financial Snapshot
Operational & Financial Snapshot 3
Slide 5: Q3FY24 Operational Snapshot
Q3FY24 Operational Snapshot Healthcare Services 45 Owned 9,469 144,823 (Hospitals) + 66% ` 56,368 / day Owned & In-patients 6 Managed Managed Occupancy ARPOB1 Hospitals Beds YTD Dec23: 65% YTD Dec23: ` 56,823 Diagnostics & 22 Retail Health Ambulatory 634 2,142 286 129 152 care & Birthing Beds Diagno
Slide 6: Clinical Updates/New Initiatives
o Apollo BGS Hospitals, Mysuru, received the prestigious accreditation by the Board of the Quality and Accreditation Institute’s (QAI) Centre for Accreditation of Health & Social Care, India, in conjunction with the International Society for Quality in Health Care External Evaluation Association (IS
Slide 7: Q3FY24 Financial Snapshot
Q3FY24 Financial Snapshot Revenue Growth EBITDA1 Growth EBITDA1 PAT Growth (in ₹ Mio) YoY(%) (in ₹ Mio) YoY(%) Margin (%) (in ₹ Mio) YoY(%) Healthcare Services 24,635 12% 5,860 8% 23.8% 2,872 9%2 Offline PD^ 18,244 15% 1,341 8% 7.3% Health Co (276) NA 19 Online PD^ & 27% (1,322)* NA 2,249 24|7 AHLL
Slide 8: YTD Dec23 Financial Snapshot
YTD Dec23 Financial Snapshot Revenue Growth EBITDA1 Growth EBITDA1 PAT Growth (in ₹ Mio) YoY(%) (in ₹ Mio) YoY(%) Margin (%) (in ₹ Mio) YoY(%) Healthcare Services 73,044 13% 17,627 10% 24.1% 8,648 14%2 Offline PD^ 51,388 15% 3,894 10% 7.6% Health Co (1,779) NA (934) Online PD^ & NA 6,614 45% (4,828)
Slide 9: Consolidated Financials
Consolidated Financials 8
Slide 10: Consolidated Financials Q3 FY24
Consolidated Financials Q3 FY24 Digital Health Healthcare Diagnostics & ` Mio Total Revenues EBITDA (Pre 24|7 Cost) Services 24,636 5,860 Retail Health 3,377 259 & Pharmacy Distribution 20,493 1,575 Consol 48,506 7,694 - Overall Consolidated Revenue grew by 14% to ` 48,506 mio. margin (%) 23.8% 7.7%
Slide 11: Consolidated Financials YTD Dec23
Consolidated Financials YTD Dec23 Digital Health & Healthcare Diagnostics & ` Mio Pharmacy Consol Services Retail Health Distribution Health HCS AHLL Total Revenues 73,045 10,107 58,002 141,153 Co EBITDA (Pre 24|7 Cost) 17,627 809 4,635 23,071 margin (%) 24.1% 8.0% 8.0% 16.3% Gross Debt 21,535 5,985
Slide 12: Healthcare Services
Healthcare Services Hospitals 11
Slide 13: Consolidated Healthcare Services Performance
Consolidated Healthcare Services Performance ` Mio Q3 FY24 Q3 FY23 YoY YTD Dec 23 YTD Dec 22 YoY No of Hospitals Operating beds 45 7911 43 7855 1% 7911 45 43 7855 1% - HCS Revenue grew by 12% in Q3FY24 (Volume grew by 7.7% excluding Institutional segment) Occupancy Revenue EBITDA (Post Ind AS 116) 6
Slide 14: Region wise Operational Parameters Q3FY24
Region wise Operational Parameters Q3FY24 Tamilnadu Region AP, Telengana Region Karnataka Region Total (7) (Chennai & ROTN)(1) (Hyderabad & others)(2) (Bangalore & others)(3) Particulars Q3 FY 23 Q3 FY 24 yoy (%) Q3 FY 23 Q3 FY 24 yoy (%) Q3 FY 23 Q3 FY 24 yoy (%) Q3 FY 23 Q3 FY 24 yoy (%) No. of Op
Slide 15: Region wise Operational Parameters YTD Dec 23
Region wise Operational Parameters YTD Dec 23 Tamilnadu Region AP, Telengana Region (Hyderabad Karnataka Region Total (6) (2) (3) (Chennai & others) (1) & others) (Bangalore & others) Particulars YTD Dec 22 YTD Dec 23 yoy (%) YTD Dec 22 YTD Dec 23 yoy (%) YTD Dec 22 YTD Dec 23 yoy (%) YTD Dec 22 YTD
Slide 16: Strong ROCE across Metros and Non Metros
Strong ROCE across Metros and Non Metros Metros: Chennai, Hyderabad, Bangalore, Mumbai, Kolkata and Delhi Non Metros (includes Tier1 & Tier2 cities) Metros Non Metros Ahmedabad, Bhubaneshwar, Lucknow, Indore Guwahati, Madurai, Trichy, Nellore,Vizag, Mysore, Nashik, Bilaspur, Karimnagar, Karur, Karai
Slide 17: Healthcare Services: Expansion Plan
Healthcare Services : Expansion Plan Total Census Project Cost Project Nature Remarks Beds Beds (in Crs) Expected commisioning : FY25 Gachibowli, Hyderabad Greenfield - Asset Light 375 300 ₹ 370 Q4 FY25 Bangalore Brownfield 150 110 ₹ 150 Q4 FY25 Sonarpur Kolkata Hospital Asset Acquisition 220 180 ₹
Slide 18: Diagnostics & Retail Health
Diagnostics & Retail Health Apollo Health & Lifestyle Ltd 17
Slide 19: Executive Summary
Executive Summary ➢ CIE (Clinical Intelligence Engine) backed condition management programs for chronic ailments ➢ Integrated Primary Care & Diagnostics strategy for symbiotic network expansion & improving operating parameters (TAT, Quality Primary Care of reports, Margins) ➢ Aggressive push on driv
Slide 20: Financial Performance Q3FY24
Financial Performance Q3FY24 Q3 FY24 Clinics Diagnostics Sugar Dental Dialysis Cradles (IP) IVF Spectra (IP) Network 286 2,142 70 152 129 11 17 11 Footfalls/Day* 2,643 14,753 481 212 1,998 57 41 74 Gross ARPP (Rs.)* 2,019 731 2,879 6,343 1,627 105,108 41,214 96,178 Gross Revenue ` Mio Q3 FY24 Q3 FY2
Slide 21: Financial Performance YTD Dec23
Financial Performance YTD Dec23 YTD Dec 23 Clinics Diagnostics Sugar Dental Dialysis Cradles (IP) IVF Spectra (IP) Network 286 2,142 70 152 129 11 17 11 Footfalls/Day* 2,527 14,934 493 226 1,929 54 42 74 Gross ARPP (Rs.)* 2,043 743 3,030 6,368 1,620 104,393 39,862 99,675 ` Mio Diagnostics Primary Ca
Slide 22: Diagnostics: Key Parameters
Diagnostics : Key Parameters Gross Revenue (INR Mn)1 1,239 EBITDA (INR Mn)2 Operational footprint 1,122 1,040 1,031 1,075 3 (as of Dect 31, 2023) 940 16 4 816 118 15 24 12% 99 14% ~300+ 1,236 10% Cities 1,016 1,059 1,118 5% 7% 922 916 148 149 presence 717 5% 5% 75 112 39 51 50 Q1 FY23 Q2 FY23 Q3 FY2
Slide 23: Digital Health & Pharmacy Distribution
Digital Health & Pharmacy Distribution Apollo Health Co 22
Slide 24: India's Largest Omni-Channel Healthcare Platform
India’s Largest Omni-Channel Healthcare Platform Apollo 247 –Digital Platform Apollo Pharmacy Platform Added As at Dectember 31, 2023 Q3 24 131 ~31 Mn+ ~6.2 Lakh* ~6,776 Closed 12 Registrations Daily Active Users Doctors Q3 24 Net 119 (I) Chandigarh: 5 Doctor Consultation Daily Consultation Himachal
Slide 25: Apollo HealthCo Financials Q3 FY24
Apollo HealthCo Financials Q3 FY24 Online Pharmacy ` Mio Offline Pharmacy Distribution & Total Health Healthco ( Q3’FY 24 vs Q3’FY 23) : Distribution Co Apollo 247 o 17% growth in revenue in Q3 FY24 Vs Q3 FY23 Total Revenues 18,244 2,249 20,493 EBITDA (Post Ind AS 116)* 1,341 235 1,575 o EBITDA posi
Slide 26: Apollo HealthCo Financials YTD Dec23
Apollo HealthCo Financials YTD Dec23 Online Pharmacy ` Mio Offline Pharmacy Distribution & Total Health Healthco : Distribution Co Apollo 247 o Platform GMV : Rs 20,064 Mn in YTD Dec 23, growth of 91% over YTD Dec 22 Total Revenues 51,388 6,614 58,002 EBITDA (Post Ind AS 116)* 3,894 741 4,635 o 81%
Slide 27: Annexure
Annexure 26
Slide 28: Basis of Consolidation
Basis of Consolidation AHEL AHEL Standalone Hospitals (100% Ownership) Location Subsidiaries Location Description Ownership Chennai Main Chennai Material Subs ACI - Chennai Chennai Apollo Health Co limited India Digital Omni-Channel Healthcare services 100.00% Tondiarpet - Chennai Chennai Apollo Hea
Slide 29: IND AS 116: Impact on P&L and Balance Sheet – Q3FY24
` Mio IND AS - 116 : Impact on P&L and Balance Sheet – Q3FY24 AHEL Standalone (post IND AS 116) AHEL Consolidated (post IND AS 116) Balance sheet Profit & Loss Balance sheet Profit & Loss Right of use 8,933 Revenue Right of use 15,908 Revenue Asset Asset Other 232 Other as of as of 556 expenses 31st
Slide 30: Thank you!
Thank you ! 29
Apollo Hospitals Enterprise — Q3 FY24 Earnings Presentation on 6ix